ArticleGeroScience2026
Unequal healthy ageing trajectories across Europe: socioeconomic development and age-related disease burden in the European Union and South-Eastern European countries.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although life expectancy has increased, many of the added years are lived in poor health, highlighting growing inequalities in ageing trajectories. Despite the increasing need for ageing-related health strategies, non-EU European countries remain underrepresented in comparative research, leaving limited evidence on healthy ageing disparities between EU and South-Eastern European (SEE) nations. This study explored variations in key health and socioeconomic indicators of societal ageing and age-related disease burden among individuals aged 70 and older across European countries, with a focus on EU and non-EU SEE nations. Data for 33 European countries were extracted from Global Burden of Disease 2021 study. Indicators included mortality, years lived with disability (YLD), healthy life expectancy (HALE), current health expenditure (HE), and Human Development Index (HDI). Hierarchical cluster analysis was used to classify EU countries, and SEE countries were analysed separately. Trends in mortality, YLD rates, and HALE were analysed using Joinpoint regression. Spearman's rank correlation was used to assess relationships between health, socioeconomic factors, and disease burden. Western and Northern European countries showed the most favourable values for indicators, while SEE countries exhibited the highest all-cause and cardiovascular mortality and the lowest HALE and HDI values. Across all countries, strong negative correlations were observed between HE, HDI, HALE, and total mortality (r = -0.81, -0.82, and -0.92, p < 0.001; respectively). Regionally adjusted and coordinated policies are needed to reduce inequalities and promote healthy ageing across Europe. Such strategic integration is essential to narrowing the gaps in ageing trajectories and socioeconomic development between EU and SEE countries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.